Biomarker discordance between primary breast cancer and bone or bone marrow metastases.

CONCLUSIONS: Biomarker discordance in bone or bone marrow lesions is common in patients with breast cancer. An accurate and thorough analysis of biomarkers and metastatic tumor properties is important for clinical decision-making.
PMID: 30793198 [PubMed - as supplied by publisher]

Source: Clinical Breast Cancer - February 22, 2019 Category: Cancer & Oncology Authors: Yuda S, Shimizu C, Yoshida M, Shiino S, Kinoshita T, Maeshima AM, Tamura K Tags: Jpn J Clin Oncol Source Type: research